Abstract Title: currently loading...

information currently loading...

Loading ... please wait
timer Loading ... please wait

Free Paper Session 2: Vascular Diseases Session

Date/Time: | Room:

Back to Previous



09:06:00 A. Abdelhamid Kuwait Quantitative assessment of outer retinal layer and photoreceptor outer segment layer and their relation to visual acuity in diabetic macular edema
09:12:00 J. Garcia-Arumi Spain A phase IV study to assess efficacy and safety of a treatandextend regimen of aflibercept for treatment of macular edema secondary to central retinal vein occlusion in naïve patients. Neuton study
09:18:00 I. Kozak United Arab Emirates Management of Coats’ disease microaneurysms with FFAguided navigated laser
09:24:00 I. Carneiro Portugal Multimodal imaging and functional correlation with microperimetry in patients with macular telangiectasia type 2
09:30:00 L. Schmetterer Singapore Relationship of dietary fish intake to diabetic retinopathy in patients with type 2 diabetes
09:36:00 P. Dugel United States Randomized, prospective, doublemasked, controlled phase 2b trial to evaluate the safety & efficacy of ALG1001 (Luminate®) in diabetic macular edema (DME)
09:42:00 S. Gómez Sánchez Spain Influence of the vitreomacular interface on the course of diabetic macular edema (DME) after treatment with intravitreal injections of antivascular endothelial growth factor agents (antiVEGF)
09:48:00 R. Figueiredo Portugal Choroidal structure changes in diabetic patients without diabetic retinopathy
09:54:00 A. Augustin Germany The first report comparing the 3 year outcomes of ILUVIEN (fluocinolone acetonide) in vitrectomised and nonvitrectomised eyes in patients with DME – results from RETROIDEAL
10:00:00 H. Zhang China Effect of intravitreal conbercept on aqueous humor cytokines in macular edema secondary to central retinal vein occlusion
10:06:00 A. Alé-Chilet Spain Cardiovascular risk factors impact in perifoveal flow in type 1 diabetes mellitus assessed by OCT angiography
10:12:00 M. Inatani Japan Efficacy and safety of intravitreal aflibercept injection in Japanese patients with neovascular glaucoma: Outcomes from the phase 3 VEGA study
10:18:00 A. Korol Ukraine Ranibizumab versus aflibercept for myopic choroidal neovascularization: 24 month results in reallife data

Want to find out more about EURETINA activities?

Contact us
© EURETINA All rights reserved